178 related articles for article (PubMed ID: 38463100)
21. Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises.
Soren UK; Mohanty PK; Meher S; Sukla SK; Hiregoudar M
Indian J Med Res; 2022 Jul; 156(1):122-129. PubMed ID: 36510904
[TBL] [Abstract][Full Text] [Related]
22. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia.
Athale UH; Chintu C
East Afr Med J; 1994 Jun; 71(6):388-91. PubMed ID: 7835262
[TBL] [Abstract][Full Text] [Related]
23. Myocardial ischaemia in sickle cell anaemia: evaluation using a new scoring system.
Bode-Thomas F; Hyacinth HI; Ogunkunle O; Omotoso A
Ann Trop Paediatr; 2011; 31(1):67-74. PubMed ID: 21262112
[TBL] [Abstract][Full Text] [Related]
24. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
25. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
[TBL] [Abstract][Full Text] [Related]
26. Proteinuric and nonproteinuric chronic kidney disease among patients with sickle cell anaemia (HbSS) attending a tertiary hospital in north-eastern Nigeria.
Sulaiman MM; Ladu AI; Abba AM; Bukar AA
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):214-217. PubMed ID: 33065100
[TBL] [Abstract][Full Text] [Related]
27. Testicular Volume in Children with Sickle Cell Anaemia in Uyo, a South-South Nigerian City.
Okorie OO; Eyong ME; Ekrikpo UE; Ekanem EE
J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34561714
[TBL] [Abstract][Full Text] [Related]
28. Impact of oral
Onalo R; Cilliers A; Cooper P
Am J Cardiovasc Dis; 2021; 11(1):136-147. PubMed ID: 33815929
[TBL] [Abstract][Full Text] [Related]
29. Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT).
Uyoga S; Olupot-Olupot P; Connon R; Kiguli S; Opoka RO; Alaroker F; Muhindo R; Macharia AW; Dondorp AM; Gibb DM; Walker AS; George EC; Maitland K; Williams TN
Lancet Child Adolesc Health; 2022 Sep; 6(9):606-613. PubMed ID: 35785794
[TBL] [Abstract][Full Text] [Related]
30. Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies.
Ferreira WA; Chweih H; Lanaro C; Almeida CB; Brito PL; Gotardo EMF; Torres L; Miguel LI; Franco-Penteado CF; Leonardo FC; Garcia F; Saad STO; Frenette PS; Brockschnieder D; Costa FF; Stasch JP; Sandner P; Conran N
J Pharmacol Exp Ther; 2020 Sep; 374(3):469-478. PubMed ID: 32631869
[TBL] [Abstract][Full Text] [Related]
31. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.
Benkerrou M; Alberti C; Couque N; Haouari Z; Ba A; Missud F; Boizeau P; Holvoet L; Ithier G; Elion J; Baruchel A; Ducrocq R
Br J Haematol; 2013 Dec; 163(5):646-54. PubMed ID: 24117340
[TBL] [Abstract][Full Text] [Related]
32. Mean Platelet Volume can Predict Cerebrovascular Events in Patients with Sickle Cell Anemia.
Celik T; Unal S; Ekinci O; Ozer C; Ilhan G; Oktay G; Arica V
Pak J Med Sci; 2015; 31(1):203-8. PubMed ID: 25878644
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure indices and disease severity in patients with sickle cell anaemia.
Aneke JC; Adegoke AO; Osho PO; Okocha EC; Nancy IC; Akintola NO; Durosinmi MA
Niger J Med; 2016; 25(1):60-9. PubMed ID: 29963822
[TBL] [Abstract][Full Text] [Related]
34. Haematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patients.
Isgrò A; Paciaroni K; Gaziev J; Sodani P; Gallucci C; Marziali M; Angelis GD; Alfieri C; Ribersani M; Roveda A; Akinyanju OO; Wakama TT; Olowoselu FO; Adediran A; Lucarelli G
Niger Med J; 2015; 56(3):175-9. PubMed ID: 26229224
[TBL] [Abstract][Full Text] [Related]
35. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
Darbari DS; Nouraie M; Taylor JG; Brugnara C; Castro O; Ballas SK
Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
[TBL] [Abstract][Full Text] [Related]
36. Significance of platelet activation in sickle cell anaemia.
Ibanga IA
Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
[TBL] [Abstract][Full Text] [Related]
37. Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications.
Obeagu EI; Ubosi NI; Obeagu GU; Egba SI; Bluth MH
Medicine (Baltimore); 2024 Jan; 103(2):e36898. PubMed ID: 38215146
[TBL] [Abstract][Full Text] [Related]
38. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
39. Malnutrition in sickle cell anemia: Prevalence, impact, and interventions: A Review.
Obeagu EI; Obeagu GU
Medicine (Baltimore); 2024 May; 103(20):e38164. PubMed ID: 38758879
[TBL] [Abstract][Full Text] [Related]
40. Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis.
Akinlade KS; Adewale CO; Rahamon SK; Fasola FA; Olaniyi JA; Atere AD
Niger Med J; 2014 Sep; 55(5):428-31. PubMed ID: 25298610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
